|
ATG4C
Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes. Highly expressed in skeletal muscle, heart, liver and testis. Inhibited by N-ethylmaleimide. Belongs to the peptidase C54 family. Note: This description may include information from UniProtKB.
|
| Protein type: Autophagy; Ubiquitin conjugating system; EC 3.4.22.-; Protease |
|
Cellular Component: cytoplasm; extracellular region; cytosol
|
|
Molecular Function: peptidase activity; cysteine-type endopeptidase activity
|
|
Biological Process: autophagy; proteolysis; protein targeting to membrane; autophagic vacuole formation
|
|
Reference #:
Q96DT6 (UniProtKB)
|
| Alt. Names/Synonyms: APG4 autophagy 4 homolog C; APG4-C; APG4C; ATG4 autophagy related 4 homolog C (S. cerevisiae); ATG4C; AUT-like 1, cysteine endopeptidase; AUT-like 3 cysteine endopeptidase; AUTL1; AUTL3; Autophagin-3; Autophagy-related cysteine endopeptidase 3; Autophagy-related protein 4 homolog C; Cysteine protease ATG4C; FLJ14867 |
| Gene Symbols: ATG4C |
|
Molecular weight: 52,497 Da
|
|
Basal Isoelectric point: 5.65
Predict pI for various phosphorylation states
|
|
CST Pathways:
Autophagy Signaling
|
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®
|